Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 258

1.

VEGF Manipulation in Glioblastoma.

Weathers SP, de Groot J.

Oncology (Williston Park). 2015 Oct;29(10):720-7. Review.

2.

Intramedullary Spinal Cord Tumors: Part I-Epidemiology, Pathophysiology, and Diagnosis.

Samartzis D, Gillis CC, Shih P, O'Toole JE, Fessler RG.

Global Spine J. 2015 Oct;5(5):425-35. doi: 10.1055/s-0035-1549029. Epub 2015 Mar 31. Review.

3.

Cancer stem cells in glioblastoma.

Lathia JD, Mack SC, Mulkearns-Hubert EE, Valentim CL, Rich JN.

Genes Dev. 2015 Jun 15;29(12):1203-17. doi: 10.1101/gad.261982.115. Review.

4.

Neuropilin-1 as Therapeutic Target for Malignant Melanoma.

Graziani G, Lacal PM.

Front Oncol. 2015 Jun 3;5:125. doi: 10.3389/fonc.2015.00125. eCollection 2015. Review.

5.

Dysphasia and phantosmia as first presentation of multifocal cerebral anaplastic astrocytomas: case report and review of the literatures.

Kong X, Wang Y, Liu S, Lu Z, Wu H, Mao X, Cheng X, Gao J, Guan J, Yang Y, Li Y, Xing B, Ma W, Wang R.

Medicine (Baltimore). 2015 May;94(20):e877. doi: 10.1097/MD.0000000000000877. Review.

6.

5-ALA Fluorescence Image Guided Resection of Glioblastoma Multiforme: A Meta-Analysis of the Literature.

Eljamel S.

Int J Mol Sci. 2015 May 7;16(5):10443-56. doi: 10.3390/ijms160510443. Review.

7.

Transforming growth factor β and bone morphogenetic protein actions in brain tumors.

Caja L, Bellomo C, Moustakas A.

FEBS Lett. 2015 Jun 22;589(14):1588-97. doi: 10.1016/j.febslet.2015.04.058. Epub 2015 May 6. Review.

8.

An intraventricular meningioma and recurrent astrocytoma collision tumor: a case report and literature review.

Zhang D, Yu J, Guo Y, Zhao S, Shao G, Huang H.

World J Surg Oncol. 2015 Feb 12;13:37. doi: 10.1186/s12957-015-0436-6. Review.

9.

Therapeutic control and resistance of the EGFR-driven signaling network in glioblastoma.

Azuaje F, Tiemann K, Niclou SP.

Cell Commun Signal. 2015 Mar 31;13:23. doi: 10.1186/s12964-015-0098-6. Review.

10.

Severe cholestatic hepatitis due to temozolomide: an adverse drug effect to keep in mind. Case report and review of literature.

Grieco A, Tafuri MA, Biolato M, Diletto B, Di Napoli N, Balducci N, Vecchio FM, Miele L.

Medicine (Baltimore). 2015 Mar;94(12):e476. doi: 10.1097/MD.0000000000000476. Review.

11.

Glioblastoma: molecular pathways, stem cells and therapeutic targets.

Jhanwar-Uniyal M, Labagnara M, Friedman M, Kwasnicki A, Murali R.

Cancers (Basel). 2015 Mar 25;7(2):538-55. doi: 10.3390/cancers7020538. Review.

12.

Pilocytic astrocytoma: pathology, molecular mechanisms and markers.

Collins VP, Jones DT, Giannini C.

Acta Neuropathol. 2015 Jun;129(6):775-88. doi: 10.1007/s00401-015-1410-7. Epub 2015 Mar 20. Review.

13.

Concurrence of multiple sclerosis and brain tumors.

Plantone D, Renna R, Sbardella E, Koudriavtseva T.

Front Neurol. 2015 Mar 4;6:40. doi: 10.3389/fneur.2015.00040. eCollection 2015. Review. No abstract available.

14.

Spinal pleomorphic xanthoastrocytoma companied with periventricular tumor.

Zhao X, Jiang X, Wang X.

Int J Clin Exp Pathol. 2015 Jan 1;8(1):1036-40. eCollection 2015. Review.

15.

The evolution of the EGFRvIII (rindopepimut) immunotherapy for glioblastoma multiforme patients.

Paff M, Alexandru-Abrams D, Hsu FP, Bota DA.

Hum Vaccin Immunother. 2014;10(11):3322-31. doi: 10.4161/21645515.2014.983002. Review.

16.

Practical management of bevacizumab-related toxicities in glioblastoma.

Brandes AA, Bartolotti M, Tosoni A, Poggi R, Franceschi E.

Oncologist. 2015 Feb;20(2):166-75. doi: 10.1634/theoncologist.2014-0330. Epub 2015 Jan 7. Review.

17.

[Prediction of the molecular response to pertubations from single cell measurements].

Remacle F, Levine RD.

Med Sci (Paris). 2014 Dec;30(12):1129-35. doi: 10.1051/medsci/20143012016. Epub 2014 Dec 24. Review. French.

18.

Spinal cord ependymomas and the appearance of other de novo tumors: a systematic review.

Fotakopoulos G, Vagkopoulos K, Gatos C, Kotlia P, Brotis A.

J Med Case Rep. 2014 Dec 18;8:438. doi: 10.1186/1752-1947-8-438. Review.

19.

Glioblastoma multiforme formation and EMT: role of FoxM1 transcription factor.

Wang Z, Zhang S, Siu TL, Huang S.

Curr Pharm Des. 2015;21(10):1268-71. Review.

20.

Glioblastoma stem-like cells: at the root of tumor recurrence and a therapeutic target.

Jackson M, Hassiotou F, Nowak A.

Carcinogenesis. 2015 Feb;36(2):177-85. doi: 10.1093/carcin/bgu243. Epub 2014 Dec 11. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk